15Jul
BioZen Therapeutics Inc. Completes Strategic Acquisition of SterSol Private Limited
Dear Valued Business Partners,
We are pleased to announce a significant milestone in BioZen's growth journey. BioZen Therapeutics Inc. has successfully acquired SterSol Private Limited, a specialized manufacturer of high-quality buffer solutions. This strategic acquisition strengthens our manufacturing capabilities, expands our product portfolio, and enhances our ability to serve the evolving needs of the global biopharmaceutical and life sciences industries.
Together, We Now Offer:
- Expanded Manufacturing Capacity for ready-to-use and customized buffer solutions
- Broader GMP-Compliant Product Portfolio meeting rigorous quality standards
- Enhanced Supply Security through dual-site manufacturing operations in the United States and India
- Stronger Global Presence with improved logistics and localized customer support
- Advanced Technical Expertise to support process development through commercial manufacturing
Most importantly, our commitment to quality, regulatory compliance, reliability, and customer service remains unchanged. This acquisition allows us to deliver greater value while maintaining the high standards you expect from BioZen.
We sincerely appreciate your continued trust and partnership and look forward to supporting your future success with an even stronger global platform.
Should you have any questions or wish to discuss how our expanded capabilities can support your upcoming projects, we would be delighted to connect.